ErbB-4 ribozymes abolish neuregulin-induced mitogenesis

Cancer Research

Volumn 58, Issue 15, 1998, Pages 3415-3422

  Tang, Careen K ^a   Goldstein, David J ^a   Payne, Jennifer ^a   Czubayko, Frank ^a   Alimandi, Maurizio ^b   Wang, Ling Mei ^b   Pierce, Jacalyn H ^b   Lippman, Marc E ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL-FREE SYSTEM; CELLS, CULTURED; DNA; DOWN-REGULATION; GLYCOPROTEINS; HEMATOPOIETIC SYSTEM; HUMANS; INTERLEUKIN-3; MICE; NEUREGULINS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, CATALYTIC; RNA, MESSENGER; STIMULATION, CHEMICAL; SUBSTRATE SPECIFICITY;

EID: 0032146730     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Gullick, W. J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancer cells. Br. Med. Bull., 47: 87-98, 1991.
2. Hynes, N. E., and Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochem. Biophys. Acta, 1198: 165-184, 1994.
3. Lemoine, N. R., Barnes, D. M., Hollywood, D. P., Hughes, C. M., Smith, P., Dublin, E., Prigent, S. A., Gullick, W. J., and Hurst, H. C. Expression of the ErbB3 gene product in breast cancer. Br. J. Cancer, 66: 1116-1121, 1992.
4. Xu, Y. H., Ishii, S., Clark, A. J., Sullivan, M., Wilson, R. K., Ma, D. P., Roe, B. A., Merlino, G. T., and Pastan, I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs over-produced in A431 carcinoma cells. Nature (Lond.), 309: 806-810, 1984.
5. r tumor antigen. Nature (Lond.), 312: 513-516, 1984.
6. Kraus, M. H., Issing, W., Miki, T., Popeson, N. C., and Aaronson, S. A. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA, 86: 9193-9197, 1989.
7. Plowman, G. D., Whitney, G. S., Neubauer, M. G., Green, J. M., McDonald, V. L., Todaro, G. J., and Shoyab, M. Molecular cloning and expression of an additional epidermal growth factor receptor related gene. Proc. Natl, Acad. Sci. USA, 87: 4905-4909, 1990.
8. Plowman, G. D., Colouscou, J. M., Whitney, G. S., Green, J. M., Carton, G. W., Foy, L., Newbaner, M. G., Shoyab, M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA, 90: 1746-1750, 1993.
9. neu protein and EGF receptor modulates EGF receptor function. Cell, 61: 1339-1347, 1990.
10. Goldman, R., Ben-Levy, R., Peles, E., and Yarden, Y. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells a mechanism for receptor transregulation. Biochemistry, 29: 11024-11028, 1990.
11. Carraway, K. L., III, and Cantley, L. C. A neu acquaintance for erbB-3 and erbB-4: a role for receptor heterodimerization in growth signaling. Cell, 78: 5-8, 1994.
12. Earp, S. H., Dawson, T. L., Li, X., and Yu, H. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat., 35: 115-132, 1995.
13. Savage, C. R., Jr., Inagami, T., and Cohen, S. The primary structure of epidermal growth factor. J. Biol. Chem., 241: 7612-7621, 1972.
14. Marquardt, H., Hunkapiller, M. W., Hood, L. E., and Todaro, G. J. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science (Washington DC), 223: 1079-1082, 1983.
15. Shoyab, M., Plowman, G. D., McDonald, V. L., Bradley, J. G., and Todaro, G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science (Washington DC), 243: 1079-1082, 1989.
16. Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., and Klagsbrun, M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (Washington DC), 251: 936-939, 1991.
17. Shing, Y., Christofori, G., Hanahan, D., Ono, Y., Sasada, R., Igarashi, K., and Folkman, J. Betacellulin. A mitogen from pancreatic cell tumors. Science (Washington DC). 259: 1604-1607, 1993.
18. erbB-2. Science (Washington DC), 256: 1205-1210, 1992.
19. Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Benlevy, R., Koski, R. A., Lu, H. S., and Yarden, Y. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell. 69: 559-572, 1992.
20. Falls, D. G., Rosen, K. M., Corfas, G., Lane, W. S., and Fischbach, G. D. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the Neu ligand family. Cell. 72: 801-815, 1993.
21. Marchionni, M. A., Goodeart, A. D. J., Chen, M. S., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., Wroblewski, D., Lynch, C., Baldassare, M., Hues, I., Davis, J. B., Hsuan, J. J., Totty, N. F., Otsu, M., Mcburney, R. N., Waterfield, M. D., Stroobant, P., and Gwynne, D. Glial growth factors are alternatively spliced erbB-2 ligands expressed in the nervous system. Nature (Lond.), 362: 312-318, 1993.
22. Lupu, R., Colomer, R., Zugmaier, G., Sarup, J., Shepard, M., Slamon, D., and Lippman, M. E. Direct interaction of a ligand for die erbB-2 oncogene product with the EGF receptor and p185erbB-2. Science (Washington DC), 249: 1552-1555, 1990.
23. erbB-4. Nature (Lond.), 366: 473-475, 1993.
24. Carraway, K. L., III, Sliwkowski, M. X., Akita, R. W., Platko, J. V., Guy, P. M., Nuijens, A., Diamonti, A. J., Vandlen, R. L., Cantley, L. C., and Cerione, R. A. The erbB-3 gene product is a receptor for heregulin. J. Biol. Chem., 269: 14303-14306, 1994.
25. Tzahar, E., Levkowitz, G., Karunagaran, D., Yi. L., Peles, E., Lavi, S., Chang, D., Liu, N., Yayon, A., Wen, D., and Yarden, Y. erbB-3 and erbB-4 function as the respective low and high affinity receptors of all neu differentiation factor/heregulin isoforms. J. Biol. Chem., 269: 40, 25226-25233, 1994.
26. Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., and Yarden, Y. Cell type specific interaction of neu differentiation factor (NDF/heregulin) with Neu/Her-2, suggests complex ligand-receptor relationships. EMBO J., 12: 961-971, 1993.
27. Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., and Carraway, K. L., III. Coexpression of erbB-2 and erbB-3 proteins reconstitute a high affinity receptor for heregulin. J. Biol. Chem., 269: 14661-14665, 1994.
28. Riese, D. J., Raaij, T. M. V., Plowman, G. D., Andrews, G. C., and Stern, D. F. The cellular response to neuregulins is governed by complex interactions of the erbB-receptor family. Mol. Cell. Biol., 15: 5770-5776, 1995.
29. Elenius, K., Paul, S., Allison, G., Sun, J., and Klagsbrun, M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J., 16: 1268-1278, 1997.
30. Jardines, L., Weiss, M., Fowble, B., and Greene, M. neu (c-erbB-2/HER2), and the epidermal growth factor receptor in breast cancer. Pathobiology, 61: 268-282, 1993.
31. Cameron, F. H., and Jennings, P. A. Specific gene suppression by engineered ribozymes in monkey cells. Proc. Natl. Acad. Sci. USA, 85: 9139-9143, 1989.
32. Scanlon, K. J., Funoto, T., Wang, W., Tone, T. J., Rossi, J., and Kashani-Sabet, M. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc. Natl. Acad. Sci. USA, 88: 10591-10595, 1991.
33. Kashani-Sabet, M., Funoto, T., Tone, T, J., Jiao, L., Wang, W., Yoshida, E., Kashfinn, B. I., Shitara, T., Wu, A. M., Moreno, J. G., Traweek, S. T., Ahlering, T. E., and Scanlon, K. J. Reversal of malignant phenotype by an anti-ras ribozyme. Antisense Res. Dev., 2: 3-15, 1992.
34. Alimandi, M., Wang, L. M., Bottaro, D., Lee, C. C., Kuo, A., Frankel, M., Di Flore, P. P., Tang, C., Lippman, M., and Pierce, J. H. EGF-mediated signal transduction through co-expressed ErbB-2 and ErbB-3 receptors. EMBO J., 16: 5608-5617, 1997.
35. Goldstein, D. J., Andresson, T., Sparkowski, J. J., and Schlegel, R. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO J., 11: 4951-4959, 1992.
36. Zuker, M., and Stiegler, P. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res., 9: 133-148, 1981.
37. McCall, M. J., Hendry, P., and Jennings, P. A. Minimal sequence requirements for ribozyme activity. Proc. Natl. Acad. Sci. USA, 89: 5710-5714, 1992.
38. Pierce, J. H. Signal transduction through foreign growth factor receptors. Adv. Regul. Cell Growth, 2: 275-297, 1990.
39. Di Fiore, P. P., Segatto, O., Taylor, W. G., Aaronson, S. A., and Pierce, J. H. EGF-receptor and ErbB-2 tyrosine kinase domains confer cell specifically for mitogenic signaling. Science (Washington DC), 248: 79-83, 1990.
40. Juhl, H., Sowning, S. G., Wellstein, A., and Czubayko, F. HER-2/neu rate-limiting for ovarian cancer growth: conditional depletion of HER-2/neu by ribozyme-targeting. J. Biol. Chem., 272: 29842-29846, 1997.